Home
About Us
Help and Support
Subscribe
Company Analyst
Financial Analyst
Pipeline Analyst
Archives
Tools
Log In
Print this
Gelnique, oxybutynin gel 3% (Anturol, Gelnique 3%)
Also known as: Anturol Gel (AP-1034)
print preview
bookmark
share with colleague
General Information
Company
Antares Pharma Inc.
Description
Advanced transdermal delivery (ATD) gel formulation of oxybutynin, a competitive antagonist of M1, M2 and M3 subtypes of the muscarinic acetylcholine receptor
Molecular Target
Muscarinic acetylcholine receptor M1 (CHRM1) (HM1)
;
Muscarinic acetylcholine receptor M2 (CHRM2) (HM2)
Mechanism of Action
Undisclosed
Latest Stage of Development
Marketed
Indication
Incontinence
Partner
Daewoong Pharmaceutical Co. Ltd.
Product Summary: Number of Indications in each Phase of Development by Disease Category
More
Product Details
Archive Items are loading
Set Email Alert
dummy